Want to see JP:4935 full AI Analyst Report?
Top Page
Liberta Co., Ltd.
(4935)
Select Model
Select Model
Rating:41Neutral
Price Target:
¥144.00
▼(-41.94% Downside)
Action:Reiterated
Date:10/24/26
The score is primarily weighed down by weak financial performance—thin margins, high leverage, and recent negative operating/free cash flow. Technicals also remain strongly bearish with the price far below key moving averages and negative MACD. Valuation provides only limited support due to a negative P/E and a modest dividend yield.
Positive Factors
Revenue Growth
The acceleration in 2025 revenue indicates improving demand and renewed top-line momentum after a stagnant prior year. If maintained, stronger sales can improve operating leverage, support brand investment, and expand the company’s ability to fund product development and channel growth.
Negative Factors
Thin Profitability
Profitability remains too thin to provide a substantial buffer against operating volatility, even though revenue improved. The 2024 loss and limited 2025 margins constrain reinvestment capacity, leave little room for cost increases, and make durable earnings improvement dependent on stronger operating leverage.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The acceleration in 2025 revenue indicates improving demand and renewed top-line momentum after a stagnant prior year. If maintained, stronger sales can improve operating leverage, support brand investment, and expand the company’s ability to fund product development and channel growth.
Read all positive factors
Liberta Co., Ltd. (4935) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.12B
Dividend Yield1.34%
Average Volume (3M)2.88M
Price to Earnings (P/E)―
Beta (1Y)2.44
Revenue Growth23.15%
EPS Growth66.79%
CountryJP
Employees136
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-1.74
Shares Outstanding34,354,200
10 Day Avg. Volume1,354,820
30 Day Avg. Volume2,877,396
Financial Highlights & Ratios
PEG Ratio-0.67
Price to Book (P/B)6.16
Price to Sales (P/S)0.98
P/FCF Ratio-23.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.2
Revenue Forecast (FY)¥11.62B
Liberta Co., Ltd. Business Overview & Revenue Model
Company Description
Liberta Co.,Ltd., established in Tokyo, Japan, in 1997, operates globally, focusing on the development and sale of a wide array of goods. Its primary offerings include beauty products, everyday household items, and specialized performance apparel....
How the Company Makes Money
Liberta generates revenue primarily by selling its products to customers via wholesale distribution to retailers and through direct-to-consumer channels such as e-commerce. Its earnings are driven by product sales volume and gross margin on goods ...
Liberta Co., Ltd. Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
32
Negative
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.66B | 10.03B | 8.64B | 7.09B | 6.64B | 5.03B |
| Gross Profit | 4.31B | 4.07B | 3.34B | 2.85B | 2.60B | 2.15B |
| EBITDA | 190.42M | 372.86M | 259.90M | 318.19M | 308.32M | 286.75M |
| Net Income | -55.44M | 46.33M | -21.17M | 111.33M | 114.51M | 200.23M |
Balance Sheet | ||||||
| Total Assets | 8.56B | 7.81B | 6.51B | 5.60B | 5.40B | 2.95B |
| Cash, Cash Equivalents and Short-Term Investments | 1.34B | 1.20B | 1.01B | 880.52M | 986.20M | 947.59M |
| Total Debt | 4.83B | 4.12B | 3.44B | 2.49B | 2.44B | 825.45M |
| Total Liabilities | 7.05B | 6.22B | 4.94B | 3.97B | 3.83B | 1.63B |
| Stockholders Equity | 1.51B | 1.59B | 1.57B | 1.63B | 1.57B | 1.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -411.66M | -624.92M | 311.02M | -825.23M | 391.70M |
| Operating Cash Flow | 0.00 | -305.76M | -577.34M | 414.13M | -799.26M | 416.57M |
| Investing Cash Flow | 0.00 | -90.48M | -202.74M | -144.96M | -692.94M | -51.12M |
| Financing Cash Flow | 0.00 | 570.81M | 885.84M | -400.30M | 1.51B | -410.29M |
Liberta Co., Ltd. Technical Analysis
Negative
248.00
Price Trends
191.18
Negative
225.32
Negative
260.85
Negative
Market Momentum
-13.26
Positive
38.66
Neutral
12.96
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4935, the sentiment is Negative. The current price of 248 is above the 20-day moving average (MA) of 185.35, above the 50-day MA of 191.18, and below the 200-day MA of 260.85, indicating a bearish trend. The MACD of -13.26 indicates Positive momentum. The RSI at 38.66 is Neutral, neither overbought nor oversold. The STOCH value of 12.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4935.
Liberta Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥6.32B | 9.29 | ― | 2.39% | 0.16% | 6.35% | |
71 Outperform | ¥1.71B | 8.83 | ― | 4.98% | -6.17% | -55.84% | |
67 Neutral | ¥44.10B | 19.72 | ― | 0.89% | 13.71% | -16.12% | |
65 Neutral | ¥5.31B | 28.94 | ― | 1.61% | 3.17% | -27.27% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ¥4.93B | 13.54 | ― | ― | -14.09% | -22.72% | |
41 Neutral | ¥5.12B | -85.63 | ― | 1.34% | 23.15% | 66.79% |
* General Sector Average
JP:4935
Liberta Co., Ltd.
149.00
-237.45
-61.44%
JP:4918
Ivy Cosmetics Corporation
301.00
-16.85
-5.30%
JP:4925
HABA Laboratories, Inc.
1,672.00
48.89
3.01%
JP:4926
C'BON COSMETICS Co., Ltd.
1,240.00
65.30
5.56%
JP:4933
I-ne CO., LTD.
2,478.00
1,227.95
98.23%
JP:4934
Premier Anti-Aging Co., Ltd.
565.00
-130.00
-18.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.